NIH
clinical trial testing remdesivir plus interferon beta-1a for COVID-19
treatment begins
08/06/2020 08:30 AM EDT
The
study is anticipated to enroll more than 1,000 hospitalized adults with
COVID-19.
|
This
service is provided to you by the National
Institutes of Health.
|
No comments:
Post a Comment